BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32398600)

  • 1. Outcomes of Local Radiation and Intensified Combined Intrathecal Methotrexate and High-dose Chemotherapy for Intracranial Germ Cell Tumors.
    Yamasaki K; Okada K; Soejima T; Kosaka Y; Nagashima T; Hara J
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e551-e557. PubMed ID: 32398600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
    Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
    J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
    Kim JW; Kim WC; Cho JH; Kim DS; Shim KW; Lyu CJ; Won SC; Suh CO
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):625-31. PubMed ID: 22420971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
    Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
    Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment results and prognostic factors for intracranial nongerminomatous germ cell tumors: single institute experience.
    Lai IC; Wong TT; Shiau CY; Hu YW; Ho DM; Chang KP; Guo WY; Chang FC; Liang ML; Lee YY; Chen HH; Yen SH; Chen YW
    Childs Nerv Syst; 2015 May; 31(5):683-91. PubMed ID: 25749900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy.
    Odagiri K; Omura M; Hata M; Aida N; Niwa T; Ogino I; Kigasawa H; Ito S; Adachi M; Inoue T
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):632-8. PubMed ID: 22420962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
    Okada K; Soejima T; Sakamoto H; Hirato J; Hara J
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28572. PubMed ID: 32710713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
    Fangusaro J; Wu S; MacDonald S; Murphy E; Shaw D; Bartels U; Khatua S; Souweidane M; Lu HM; Morris D; Panigrahy A; Onar-Thomas A; Fouladi M; Gajjar A; Dhall G
    J Clin Oncol; 2019 Dec; 37(34):3283-3290. PubMed ID: 31545689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in molecular biology and treatment strategies for intracranial germ cell tumors.
    Huang X; Zhang R; Mao Y; Zhou LF; Zhang C
    World J Pediatr; 2016 Aug; 12(3):275-282. PubMed ID: 27351562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation.
    de Rezende ACP; Weltman E; Chen MJ; Helito JK; de Carvalho ÍT; Sakuraba RK; Silva NS; Cappellano AM; Hamerschlak N
    PLoS One; 2019; 14(12):e0226350. PubMed ID: 31860688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.
    Yamasaki K; Okada K; Soejima T; Sakamoto H; Hara J
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28012. PubMed ID: 31544362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy.
    Breen WG; Blanchard MJ; Rao AN; Daniels DJ; Buckner JC; Laack NNI
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28695992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors.
    Aoyama H; Shirato H; Ikeda J; Fujieda K; Miyasaka K; Sawamura Y
    J Clin Oncol; 2002 Feb; 20(3):857-65. PubMed ID: 11821471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Outcome of Response-Based Radiation Therapy in Children and Adolescents With Central Nervous System Nongerminomatous Germ Cell Tumors: Results of a Prospective Study.
    Zeng C; Yang Q; Li Z; Wei Z; Chen T; Deng M; Wang J; Wang J; Sun F; Huang J; Lu S; Zhu J; Sun X; Zhen Z
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):858-868. PubMed ID: 38122991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol].
    Göbel U; Bamberg M; Calaminus G; Gnekow AK; Herrmann HD; Lenard HG; Spaar HJ; Niethammer D; Kühl J; Harms D
    Klin Padiatr; 1993; 205(4):217-24. PubMed ID: 7690863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the Management of Childhood Intracranial Germ Cell Tumors in Middle-Income Countries: A 20-Year Retrospective Review From a Single Tertiary Center in Malaysia.
    Rajagopal R; Leong SH; Jawin V; Foo JC; Ahmad Bahuri NF; Mun KS; Azman RR; Loh J; Yap TY; Ariffin H; Moreira DC; Gottardo NG; Bouffet E; Ganesan D
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e913-e923. PubMed ID: 33633029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
    Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial Germ Cell Tumors in Adolescents and Young Adults: A 40-Year Multi-Institutional Review of Outcomes.
    Lo AC; Hodgson D; Dang J; Tyldesley S; Bouffet E; Bartels U; Cheng S; Hukin J; Bedard PL; Goddard K; Laperriere N
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):269-278. PubMed ID: 31654785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.